Skip to main content
. 2018 Sep 24;28(5):285–296. doi: 10.1089/nat.2018.0734

FIG. 4.

FIG. 4.

miRNAs can suppress off-target expression in mammals. (a) Schematic representation of mRNA with a miRts in the 3′ UTR. (bd) miRts incorporation in mRNA enables protein suppression in rodents upon mRNA delivery. Serum Epo levels 6 h after MC3-encapsulated or L2000-complexed 1-methyl-pseudouridine (m1Ψ) mRNA encoding Epo was administered intravenously to (b) mice or (c) rats. (d) Total flux (photons/s) and serum Epo levels 6 h after MC3-encapsulated m1Ψ mRNAs encoding Luc and Epo were administered intravenously to “chimeric” mice (mouse hepatocytes replaced with human hepatocytes). (e) miRts incorporation in mRNA enables protein suppression in nonhuman primates upon mRNA delivery. Serum Epo levels 6 h after MC3-encapsulated m1Ψ mRNA encoding Epo was administered intravenously to African green monkey. (f) Schematic representation of an mRNA with two different miRts's in the 3′ UTR. (g) Incorporation of different miRts's in mRNA enables protein suppression in multiple tissues upon mRNA delivery. Total flux (photons/s) from liver and spleen 6 h after MC3-encapsulated m1Ψ mRNA encoding Luc was intravenously administered to mice. Error bars represent standard deviation in the figure. Luminescence/Epo expression generated upon intravenous administration of miRts-containing mRNA was compared with levels with CTRL mRNA, and P values were generated by Prism using the unpaired, two-tailed t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.